|
Sign In to gain access to subscriptions and/or personal tools.
|
Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and aß2 glycoprotein-I is the most frequent isotype
E Diri
E Cucurull
A E Gharavi
D Kapoor
E A Mendez
E Scopelitis
Department of Medicine, Section of Rheumatology, Louisiana State University Medical Center, New Orleans, Louisiana, USA
W A Wilson
Department of Medicine, Section of Rheumatology, Louisiana State University Medical Center, 1542 Tulane Avenue, New Orleans, Louisiana, 70112-2822, USA
Antiphospholipid (Hughes') syndrome (APS) has not been reported in African-Americans (A-A) as frequently as in other ethnic groups. We describe eight A-A female patients with APS, including two cases of primary APS (PAPS), four with APS secondary to systemic lupus erythematosus (SLE), one with Sjögren's syndrome, and one with overlap connective tissue disease (CTD). Their mean age was 34 y (range 2447 y). Patients were followed for a mean of 6 y (range 0.311 y). During follow up, both anticardiolipin (aCL) and anti-b2glycoprotein-I (ab2GPI) antibodies were measured in stored sera by enzyme-linked immunosorbent assay (ELISA). IgA was the most frequent isotype of aCL and ab2GPI, and co-occurred with the IgM isotype in three of four patients with neurologic manifestations.
Key Words: anticardiolipin antibodies anti-ß2glycoprotein-I antibodies antiphospholipid syndrome African-Americans
Lupus, Vol. 8, No. 4,
263-268 (1999)
DOI: 10.1191/096120399678847812

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Qian, F. Xie, A. W. Gibson, J. C. Edberg, R. P. Kimberly, and J. Wu
Functional expression of IgA receptor Fc{alpha}RI on human platelets
J. Leukoc. Biol.,
December 1, 2008;
84(6):
1492 - 1500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wu, C. Ji, F. Xie, C. D. Langefeld, K. Qian, A. W. Gibson, J. C. Edberg, and R. P. Kimberly
Fc{alpha}RI (CD89) Alleles Determine the Proinflammatory Potential of Serum IgA
J. Immunol.,
March 15, 2007;
178(6):
3973 - 3982.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M L Bertolaccini and M A Khamashta
Laboratory diagnosis and management challenges in the antiphospholipid syndrome
Lupus,
March 1, 2006;
15(3):
172 - 178.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I Uthman and M Khamashta
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome
Ann Rheum Dis,
December 1, 2005;
64(12):
1671 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J T Merrill
Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus
Lupus,
November 1, 2004;
13(11):
869 - 876.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Ozturk, I. C. Haznedaroglu, M. Turgut, and H. Goker
Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia
Clinical and Applied Thrombosis/Hemostasis,
April 1, 2004;
10(2):
89 - 126.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Wasmuth, D. Oliver y Minarro, A. Homrighausen, L. Leifeld, J. K. Rockstroh, T. Sauerbruch, and U. Spengler
Phospholipid Autoantibodies and the Antiphospholipid Antibody Syndrome: Diagnostic Accuracy of 23 Methods Studied by Variation in ROC Curves with Number of Clinical Manifestations
Clin. Chem.,
July 1, 2002;
48(7):
1004 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V Aguirre, R Cuchacovich, L Barria, H Aris, C Trejo, L Massardo, R Pasten, and L Espinoza
Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE)
Lupus,
February 1, 2001;
10(2):
75 - 80.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A Shrivastava, S Dwivedi, A Aggarwal, and R Misra
Anti-cardiolipin and anti-beta 2 glycoprotein Iantibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures
Lupus,
January 1, 2001;
10(1):
45 - 50.
[Abstract]
[PDF]
|
 |
|
|
|